[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366624-105":59,"doc-detail-366624-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","online-conference-chronic-viral-infections-and-cancer-openings-for-vaccines-and-cure-vircan2024-conference-report","Online Conference “Chronic Viral Infections and Cancer, Openings for Vaccines and Cure” - VIRCAN2024 - Conference Report","","Chronic viral infections and virus-induced cancers remain major contributors to global morbidity and mortality, with persistent viral infection, oncogenic mechanisms, and unmet needs in cure and prevention. The international online conference “VIRCAN2024: Chronic viral infections and cancer, openings for Vaccines and Cure” brought together researchers to summarize ongoing work across oncogenicity mechanisms, diagnostics, and emerging vaccine and treatment approaches. Held at Riga Stradins University with supporting grants and the journal Vaccines, the report compiles the lectures and presentations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/online-conference-chronic-viral-infections-and-cancer-openings-for-vaccines-and-cure-vircan2024-conference-report/366624/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/online-conference-chronic-viral-infections-and-cancer-openings-for-vaccines-and-cure-vircan2024-conference-report/366624.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of the VIRCAN2024 online conference?","Question",{"text":112,"@type":113},"The conference aimed to address remaining issues in chronic viral infections and virus-induced cancers, present research in the field, and outline directions for future development.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which scientific areas were covered in the conference sessions?",{"text":117,"@type":113},"Sessions covered mechanisms of viral oncogenicity, approaches to chronic viral infection and cancer cure through vaccines and treatments, and focus topics such as high-risk human papillomaviruses.",{"name":119,"@type":110,"acceptedAnswer":120},"Where and with what support was VIRCAN2024 held?",{"text":121,"@type":113},"VIRCAN2024 was held on the Riga Stradins University platform, supported by a Latvian Science Council grant, and associated with the scientific journal Vaccines (MDPI).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366624,1791066150,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Conference Report  \nOnline Conference “Chronic Viral Infections and Cancer, Openings for Vaccines and Cure” VIRCAN2024, Monitoring the Progress  \nLiba Sokolovska 1, *, Juris Jansons 1,2, Franco M. Buonaguro 3 and Maria Isaguliants 1,4, *  \nAcademic Editor: RalphA. Tripp  \nReceived: 31 July 2025  \nRevised: 23 August 2025  \nAccepted: 26 August 2025  \nPublished: 2 September 2025  \nCitation: Sokolovska, L.; Jansons, J.; Buonaguro, F.M.; Isaguliants, M. Online Conference “Chronic Viral Infections and Cancer, Openings for Vaccines and Cure”VIRCAN2024, Monitoring the Progress. Vaccines 2025, 13, 940. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)vaccines13090940  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia  \n2 Latvian Biomedical Research and Study Centers, LV-1067 Riga, Latvia  \n3 Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale,  \n80131 Naples, Italy  \n4 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177 Stockholm, Sweden  \n* Correspondence: [liba.sokolovska@rsu.lv](liba.sokolovska@rsu.lv) (L.S.); [maria.issagouliantis@rsu.lv](maria.issagouliantis@rsu.lv) (M.I.)  \nAbstract  \nChronic viral infections and virus-induced cancers have been actively studied for decades, with many significant advancements in basic science, disease cure, treatment, and prevention. Yet, today, these infections and pathologies remain major contributors to morbidity and mortality worldwide. The international online conference “VIRCAN2024: Chronic viral infections and cancer, openings for Vaccines and Cure” aimed to address the remaining issues, present the research carried out in this broad field, and prognose directions for its development. The conference covered oncogenicity mechanisms and new approaches in the development of treatments and vaccines. VIRCAN2024 was held on the platform of Riga Stradins University, Riga, Latvia. The conference was supported by the Latvian Science Council grant “Human papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms and cancer”, and the scientific journal Vaccines (MDPI) . This report summarizes the lectures and presentations given atthe conference.  \nKeywords: vircan2024; virus; infection; oncovirus; vaccine  \n1. Online Conference “VIRCAN2024: Chronic Viral Infections and Cancer, Openings for Vaccines and Cure”  \nChronic viral infections and virus-induced cancers remain major contributors to the global burden of infectious diseases and cancers, morbidity, and mortality of millions of people, as well as huge pressure on the national health care systems. Over 4% of the global population are living with chronic viral infections, such as HBV and HCV (304 million people) and HIV-1 (40.8 million) [1,2] . Nearly 10% of cancer cases worldwide are attributed to viral infections, with HPV and HBV having the highest age-standardized global incidence rates–18.5 and 3.9 per 100,000 person-years, respectively [3,4] . Even though science and medicine have made substantial progress in treating and preventing many viral infections, multiple issues remain to be addressed and resolved.  \nThe lingering problems of viral persistence and oncogenicity were addressed by the international online conference “Chronic viral infections and cancer, openings for Vaccines and Cure”(VIRCAN2024) hosted by Riga Stradins University with the support from the Latvian Science Council grant “Human papillomavirus genome associated correlates of disease progression and treatment response for cervical neoplasms  \nand ca","cbCaif5kyR51Qhla","https://ap.wps.com/l/cbCaif5kyR51Qhla","pdf",355199,24,"English","# Online Conference “VIRCAN2024: Chronic Viral Infections and Cancer, Openings for Vaccines and Cure”\n## Chronic viral infections and virus-induced cancers as a global health burden\n## Persistent viral infection and oncogenicity addressed by VIRCAN2024\n## Conference organization, sessions, and coverage","[{\"question\":\"What was the goal of the VIRCAN2024 online conference?\",\"answer\":\"The conference aimed to address remaining issues in chronic viral infections and virus-induced cancers, present research in the field, and outline directions for future development.\"},{\"question\":\"Which scientific areas were covered in the conference sessions?\",\"answer\":\"Sessions covered mechanisms of viral oncogenicity, approaches to chronic viral infection and cancer cure through vaccines and treatments, and focus topics such as high-risk human papillomaviruses.\"},{\"question\":\"Where and with what support was VIRCAN2024 held?\",\"answer\":\"VIRCAN2024 was held on the Riga Stradins University platform, supported by a Latvian Science Council grant, and associated with the scientific journal Vaccines (MDPI).\"}]","Online Conference “Chronic Viral Infections and Cancer, Openings for Vaccines and Cure” - VIRCAN2024 - Conference Report | PDF",1790166464,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6c556261d6f4a797d05b25319a683d7.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/841725d721262db7eae5a1781ae5ce12.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74db8d102fd0f916dfec508cdcc6276f.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/979896b4cb16f9c5686d07ab011e8af3.webp",980,1385]